Do you want to read an article? Please log in or register.
Defining a phenotype of severe COPD patients who develop chronic hypercapnia
COPDFurther Publications
Related content
RECOMMENDED
COPD
Dual-task performance and balance in patients with severe COPD: a cross-sectional study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Ther Adv Respir Dis
Alexandru Florian C, Camelia Corina P, Adelina M, Vlad C, Roxana Ramona O, Emil Robert S, Cristian O
doi: 10.1177/17534666241287302
COMMENTED
COPD
Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine Reduces Exacerbation Rate and Risk in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Sciurba FC, Christenson SA, Rheault T, Bengtsson T, Rickard K, Barjaktarevic IZ
doi: 10.1016/j.chest.2024.07.168
RECOMMENDED
COPD
Dietary patterns and risk of Chronic Obstructive Pulmonary Disease (COPD) and clinical outcomes in diagnosed patients: a scoping review
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Ignacio C, Bernardes S, Zanella P, Silva FM
doi: 10.1016/j.rmed.2024.107773
Asthma
Costs of Oral Corticosteroid Use in Patients with Severe Asthma With/Without Chronic Rhinosinusitis with Nasal Polyps: Data from the Italian SANI Registry
Adv Ther
Heffler E, Blasi F, Paggiaro P, Canonica GW
doi: 10.1007/s12325-024-03071-w
RECOMMENDED
Asthma
Real-Life Clinical Outcomes of Benralizumab Treatment in Patients with Uncontrolled Severe Asthma and Coexisting Chronic Rhinosinusitis with Nasal Polyposis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med
Chiner E, Murcia M, Boira I, Bernabeu MÁ, Esteban V, Martínez-Moragón E
doi: 10.3390/jcm13144247
RECOMMENDED
COPD
Use of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitor is Associated with reduced Emergency Room Visits and Hospitalization in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Diabetes Mellitus
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Shanmugavel Geetha H, Teo YX, Ravichandran S, Perkitt NR, Gogtay M, Lal A, Abraham GM, Trivedi N
doi: 10.1016/j.rmed.2024.107819
RECOMMENDED
COPD
Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Higginson IJ, Brown ST, Oluyase AO, May P, Maddocks M, Costantini M, Bajwah S, Normand C, Bausewein C, Simon ST, Ryan K, Currow DC, Johnson MJ, Hart SP, Mather H, Krajnik M, Tanzi S, Ghirotto L, Bolton CE, Janowiak P, Turola E, Jolley CJ, Murden G, Wilcock A, Farsides B, Brown JM, BETTER-B consortium
doi: 10.1016/S2213-2600(24)00187-5
RECOMMENDED
Further Publications
Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD)
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res
Trudzinski FC, Jörres RA, Alter P, Watz H, Vogelmeier CF, Kauczor HU, Thangamani S, Debic M, Welte T, Behr J, Kahnert K, Bals R, Herr C, Heußel CP, Biederer J, von Stackelberg O, Fähndrich S, Wouters EFM, Waschki B, Rabe KF, Herth FJF, Palm V, COSYCONET study group
doi: 10.1186/s12931-024-02902-2
COPD
Development and Validation of a Quantitative Score for the Criteria Clinical Control in Stable COPD Proposed in the Spanish COPD Guidelines (GesEPOC): Results of the EPOCONSUL Audit
J Clin Med
Calle Rubio M, Cataluña JJS, Miravitlles M, Navarrete BA, López-Campos JL, Ferrer MEF, Rodríguez Hermosa JL
doi: 10.3390/jcm14030707